Cy4gate S.p.A. (BIT:CY4)

Market Cap	121.39M
Revenue (ttm)	76.69M
Net Income (ttm)	-7.05M
Shares Out	23.12M
EPS (ttm)	-0.30
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	66,438
Average Volume	39,802
Open	5.23
Previous Close	5.25
Day's Range	5.23 - 5.38
52-Week Range	3.20 - 6.20
Beta	1.05
RSI	63.19
Earnings Date	Sep 12, 2025

About Ligand Pharmaceuticals

Cy4gate S.p.A. designs, develops, and produces technologies, products, systems, and services for cyber intelligence and cyber security needs for the companies, institutions, law enforcement agencies, and armed forces in Italy and internationally. The company offers CY4GARD, a forensic analysis and incident response solution; PronoCyber, a digital emergency response insurance platform against cyber-attacks and data breaches; QUIPO Enterprise, a decision intelligence software platform for improving the decision making process; and VIP’S DIGITAL B...

• Industry: Software - Infrastructure
• Sector: Technology
• Founded: 2014
• Employees: 511
• Stock Exchange: Borsa Italiana
• Ticker Symbol: CY4

Financial Performance

In 2024, Cy4gate's revenue was 75.08 million, an increase of 10.82% compared to the previous year's 67.75 million. Losses were -7.40 million, -30.86% less than in 2023.